PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
PHASE2
Background:
One way to treat liver cancer is to deliver chemotherapy drugs...
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
PHASE3
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
PHASE2
The goal of this clinical trial is to learn if additional chemotherapy by m...
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
PHASE2
RATIONALE: Drugs used in chemotherapy, such as floxuridine and dexamethason...
Status
Completed
Location
New York Weill Cornell Cancer Center at Cornell University
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
PHASE2
This study will compare the safety and effects of HAI floxuridine and dexam...
Status
Recruiting
Location
National Heart, Lung, and Blood Institute (NIH) (Data Collection Only)